Published in N Engl J Med on April 05, 1990
Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst (2010) 2.29
NMR--another cancer-test disappointment. N Engl J Med (1990) 1.04
Comment on "magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain". Science (2008) 0.86
Failure to detect early breast cancer using in vitro nuclear magnetic resonance spectroscopy of plasma. Br J Cancer (1993) 0.75
Detection of malignancy-associated metabolites in the sera of cancer patients by electron capture gas chromatography. Br J Cancer (1994) 0.75
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet (1997) 1.94
Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment. Cancer Res (1989) 1.91
A precision measurement of the mass of the top quark. Nature (2004) 1.87
Components of the metabolic syndrome in long-term survivors of testicular cancer. Ann Oncol (2006) 1.85
Some environmental and bodily characteristics of melanoma patients. A case-control study. Int J Cancer (1979) 1.76
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology (2003) 1.72
Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat (1999) 1.63
The level of physical activity in long-term survivors of testicular cancer. Eur J Cancer (2003) 1.61
Digitoxin medication and cancer; case control and internal dose-response studies. BMC Cancer (2001) 1.50
Identification of 4-hydroxy-N-desmethyltamoxifen as a metabolite of tamoxifen in human bile. Cancer Res (1988) 1.45
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience. J Clin Oncol (1991) 1.39
Body mass index and risk of breast cancer. A prospective study of 23,826 Norwegian women. Int J Cancer (1990) 1.34
Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study. Clin Cancer Res (1997) 1.22
Improved measurement of androgen receptors in human breast cancer. Cancer Res (1989) 1.20
Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res (1999) 1.19
Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Eur J Surg Oncol (1992) 1.15
The risk of spontaneous pneumothorax in patients with osteogenic sarcoma and testicular cancer. Cancer (1982) 1.12
Widowhood and divorce related to cancer risk in middle-aged women. A nested case-control study among Norwegian women born between 1935 and 1954. Int J Cancer (1994) 1.12
Body height and risk of breast cancer. A prospective study of 23,831 Norwegian women. Br J Cancer (1990) 1.11
Blood pressure and body mass index in long-term survivors of testicular cancer. J Clin Oncol (2005) 1.09
Death of a husband or marital divorce related to risk of breast cancer in middle-aged women. A nested case-control study among Norwegian women born 1935-1954. Eur J Cancer (1994) 1.07
1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed (1994) 1.07
Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway. Eur J Cancer (2004) 1.05
Chromosome analyses of nurses handling cytostatic agents. Cancer Treat Rep (1981) 1.04
Relationship of cyclic AMP binding capacity and estrogen receptor to hormone sensitivity in human breast cancer. Breast Cancer Res Treat (1983) 1.02
Association of Kaposi's sarcoma and prior immunosuppressive therapy: a 5-year material of Kaposi's sarcoma in Norway. Cancer (1978) 1.02
A phase II study of oral VP-16-213 in non-seminomatous testicular cancer. Eur J Cancer (1981) 1.00
Health technology assessment and implications for clinical practice: the case of prostate cancer screening. Scand J Clin Lab Invest (2003) 1.00
Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer. Drugs (1988) 0.99
In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue. Anticancer Res (1994) 0.99
Engineering analysis of penile hemodynamic and structural-dynamic relationships: Part I--Clinical implications of penile tissue mechanical properties. Int J Impot Res (1998) 0.99
Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer (1996) 0.98
In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans. Clin Pharmacol Ther (1990) 0.98
Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis. NMR Biomed (2000) 0.97
Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study. Eur J Cancer (1991) 0.97
The leucocyte nadir, a predictor of chemotherapy efficacy? Br J Cancer (1999) 0.94
Aminoglutethimide and warfarin. A new important drug interaction. Cancer Chemother Pharmacol (1984) 0.93
Pregnancy-related factors and risk of breast cancer in a prospective study of 29,981 Norwegian women. Eur J Cancer (1992) 0.93
Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods. J Clin Pathol (1992) 0.93
Hyperthermia induced polyphosphate changes in Propionibacterium acnes as studied by 31P NMR. Z Naturforsch C (1989) 0.92
Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Preliminary findings. Clin Pharmacokinet (1987) 0.91
Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter study. Eur J Surg Oncol (2002) 0.90
Prospective study of height, body mass index and risk of breast cancer. Acta Oncol (1992) 0.90
Does early physical maturity influence breast cancer risk? Acta Oncol (1994) 0.90
Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population. Hum Reprod (2012) 0.88
Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial. Eur J Cancer Clin Oncol (1986) 0.87
Cigarette smoking and risk of breast cancer: a prospective study of 24,329 Norwegian women. Eur J Cancer (1990) 0.87
Plasma changes in breast cancer patients during endocrine therapy--lipid measurements and nuclear magnetic resonance (NMR) spectroscopy. Breast Cancer Res Treat (1995) 0.87
Progesterone-binding cyst protein in human breast tumor cytosol. Cancer Res (1987) 0.87
Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway. Support Care Cancer (2004) 0.86
Clinical pharmacokinetics of endocrine agents used in advanced breast cancer. Clin Pharmacokinet (1992) 0.86
Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging (1994) 0.85
Partial resection of the cartilaginous nasal septum in rats; its influence on growth. Angle Orthod (1974) 0.85
Epithelial restitution and cellular proliferation after gastric mucosal damage caused by hypertonic NaCl in rats. Virchows Arch A Pathol Anat Histopathol (1988) 0.85
Protein kinases activated by cAMP in the genital tract of spayed mice treated with oestradiol-17beta. J Reprod Fertil (1975) 0.84
First direct demonstration of preferential release of citrate from astrocytes using [13C]NMR spectroscopy of cultured neurons and astrocytes. Neurosci Lett (1991) 0.84
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. J Cancer Surviv (2008) 0.84
Single-dose and steady-state pharmacokinetics of aminoglutethimide. Clin Pharmacokinet (1985) 0.83
Testicular function after combination chemotherapy for Hodgkin's disease. Scand J Haematol (1976) 0.83
Inherited predisposition to breast carcinoma. Results of first round examination of 537 women at risk. Anticancer Res (1996) 0.83
Cytosol albumin content in operable breast cancer. Correlations to steroid hormone receptors, other prognostic factors and prognosis. Acta Oncol (1991) 0.83
Ratio of jet cross sections at square root of s = 630 GeV and 1800 GeV. Phys Rev Lett (2001) 0.83
Quality of life of cancer patients with different prognoses. Qual Life Res (1994) 0.83
Determination of tamoxifen and four metabolites in serum by low-dispersion liquid chromatography. Clin Chem (1987) 0.83
Comparison of computed tomography, lymphography, and phlebography in 200 consecutive patients with regard to retroperitoneal metastases from testicular tumor. Radiology (1983) 0.83
Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I. Eur Urol (1984) 0.82
Immunocompetent cells in rat periodontal ligament and their recruitment incident to experimental orthodontic tooth movement. Eur J Oral Sci (1997) 0.82
The influence of progestins on receptor levels in breast cancer metastasis. Anticancer Res (1987) 0.82
Changes in CGRP-immunoreactive nerve fibres during experimental tooth movement in rats. Eur J Orthod (1990) 0.82
The sagittal growth of the foetal cranial base. Acta Odontol Scand (1971) 0.81
Inclusive jet production in pp(macro) collisions. Phys Rev Lett (2001) 0.81
Long-term survival and morbidity in patients with metastatic malignant germ cell tumors treated with cisplatin-based combination chemotherapy. Cancer (1986) 0.81
Determination of warfarin in human plasma by high performance liquid chromatography and photodiode array detector. Ther Drug Monit (1985) 0.81
Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas. Acta Oncol (1999) 0.81
Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer. Clin Pharmacol Ther (1984) 0.81
Growth in craniofacial cartilages studied by 3H-thymidine incorporation. Growth (1975) 0.81
Regional variations in cell proliferation and matrix formation in the cartilaginous nasal septum of the rat. [3H]-Thymidine and [35S]-sulfate incorporation studies. Growth (1977) 0.81
Cytosol protein content and prognosis in operable breast cancer. Correlations with steroid hormone receptors and other prognostic factors. Breast Cancer Res Treat (1991) 0.81
Serum hormone levels in patients with malignant testicular germ cell tumours without clinical and/or radiological signs of tumour. Br J Urol (1980) 0.81
A randomized study on hormone-resistant prostatic cancer: estramustine phosphate versus low dose epirubicin with or without medroxyprogesterone acetate. A Norwegian multicenter study. Scand J Urol Nephrol (1990) 0.81
Effect of experimental tooth movement on periodontal and pulpal blood flow. Eur J Orthod (1989) 0.80
The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer. Cancer Chemother Pharmacol (1986) 0.80
Effect of experimental tooth movement on nerve fibres immunoreactive to calcitonin gene-related peptide, protein gene product 9.5, and blood vessel density and distribution in rats. Eur J Orthod (1997) 0.80
Weekly Adriamycin vs. 4-epidoxorubicin every second week in advanced breast cancer. A randomized trial. The Norwegian Breast Cancer Group. Eur J Cancer (1990) 0.80
Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine. Cancer Res (1986) 0.80
Effect of salt-induced mucosal damage and healing on penetration of N-methyl-N'-nitro-N-nitrosoguanidine to proliferative cells in the gastric mucosa of rats. Carcinogenesis (1994) 0.80
The relationship between the cartilaginous nasal septum and maxillary growth during human fetal life. Cleft Palate J (1970) 0.80
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer. Br J Cancer (2012) 0.80
Measurement of adenylate cyclase activity by competitive binding to the free regulatory moiety of protein kinase I. Int J Biochem (1980) 0.80
Measurement of dijet azimuthal decorrelations at central rapidities in pp collisions at sqrt s =1.96 TeV. Phys Rev Lett (2005) 0.80
Blood flow and mucoid cap protect against penetration of carcinogens into superficially injured gastric mucosa of rats. Dig Dis Sci (1995) 0.79
Autogenous transplantation of the nasal septum cartilage in the rat. Arch Oral Biol (1974) 0.79